Maternus-Kliniken Aktiengesellschaft (MAK.DE)
EUR 1.49
(-2.61%)
EUR 1.49
(-2.61%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 17.48 Million EUR | -82.0% |
| 2022 | 97.12 Million EUR | 3.59% |
| 2021 | 93.75 Million EUR | -2.49% |
| 2020 | 96.14 Million EUR | -8.97% |
| 2019 | 105.61 Million EUR | 5.63% |
| 2018 | 99.99 Million EUR | 0.86% |
| 2017 | 99.14 Million EUR | 1.95% |
| 2016 | 97.24 Million EUR | 2.98% |
| 2015 | 94.42 Million EUR | 39.46% |
| 2014 | 67.7 Million EUR | -30.29% |
| 2013 | 97.12 Million EUR | 2.46% |
| 2012 | 94.79 Million EUR | 10.11% |
| 2011 | 86.08 Million EUR | 2.88% |
| 2010 | 83.67 Million EUR | -0.94% |
| 2009 | 84.46 Million EUR | 2.35% |
| 2008 | 82.52 Million EUR | 1.13% |
| 2007 | 81.6 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 5.5 Million EUR | 0.0% |
| 2023 Q3 | 2.74 Million EUR | -88.8% |
| 2023 Q4 | 2.74 Million EUR | 0.0% |
| 2023 FY | 17.48 Million EUR | -82.0% |
| 2023 Q1 | 5.85 Million EUR | -21.89% |
| 2023 Q2 | 24.46 Million EUR | 317.67% |
| 2022 FY | 97.12 Million EUR | 3.59% |
| 2022 Q2 | 24.46 Million EUR | 284.88% |
| 2022 Q3 | 6.53 Million EUR | -73.29% |
| 2022 Q1 | 6.35 Million EUR | 3.36% |
| 2022 Q4 | 7.49 Million EUR | 14.74% |
| 2021 Q1 | 6.7 Million EUR | -9.9% |
| 2021 Q3 | 5.8 Million EUR | -76.85% |
| 2021 Q2 | 25.05 Million EUR | 273.45% |
| 2021 Q4 | 6.15 Million EUR | 6.05% |
| 2021 FY | 93.75 Million EUR | -2.49% |
| 2020 Q1 | 6.36 Million EUR | -31.66% |
| 2020 Q2 | 23.64 Million EUR | 271.75% |
| 2020 FY | 96.14 Million EUR | -8.97% |
| 2020 Q3 | 6.62 Million EUR | -72.01% |
| 2020 Q4 | 7.44 Million EUR | 12.47% |
| 2019 Q3 | 7.63 Million EUR | -70.09% |
| 2019 Q2 | 25.52 Million EUR | 308.37% |
| 2019 Q1 | 6.25 Million EUR | 22.41% |
| 2019 FY | 105.61 Million EUR | 5.63% |
| 2019 Q4 | 9.3 Million EUR | 21.91% |
| 2018 Q4 | 5.1 Million EUR | 0.0% |
| 2018 Q2 | 25.36 Million EUR | 279.34% |
| 2018 FY | 99.99 Million EUR | 0.86% |
| 2018 Q1 | 6.68 Million EUR | 5.42% |
| 2018 Q3 | 5.1 Million EUR | -79.86% |
| 2017 Q2 | 25.01 Million EUR | 268.8% |
| 2017 Q3 | 6.34 Million EUR | -74.64% |
| 2017 Q4 | 6.34 Million EUR | 0.0% |
| 2017 Q1 | 6.78 Million EUR | 5.98% |
| 2017 FY | 99.14 Million EUR | 1.95% |
| 2016 Q4 | 6.39 Million EUR | 0.0% |
| 2016 FY | 97.24 Million EUR | 2.98% |
| 2016 Q2 | 24.46 Million EUR | 250.82% |
| 2016 Q3 | 6.39 Million EUR | -73.84% |
| 2016 Q1 | 6.97 Million EUR | -64.52% |
| 2015 Q4 | 19.65 Million EUR | -21.35% |
| 2015 FY | 94.42 Million EUR | 39.46% |
| 2015 Q3 | 24.99 Million EUR | -0.67% |
| 2015 Q2 | 25.16 Million EUR | 2.21% |
| 2015 Q1 | 24.61 Million EUR | 743.92% |
| 2014 Q4 | -3.82 Million EUR | -115.84% |
| 2014 Q3 | 24.13 Million EUR | -0.39% |
| 2014 Q2 | 24.23 Million EUR | 4.64% |
| 2014 Q1 | 23.15 Million EUR | -9.2% |
| 2014 FY | 67.7 Million EUR | -30.29% |
| 2013 Q4 | 25.5 Million EUR | 6.97% |
| 2013 Q3 | 23.84 Million EUR | -1.54% |
| 2013 Q2 | 24.21 Million EUR | 2.76% |
| 2013 Q1 | 23.56 Million EUR | -5.53% |
| 2013 FY | 97.12 Million EUR | 2.46% |
| 2012 Q1 | 22.47 Million EUR | 13.79% |
| 2012 Q2 | 23.92 Million EUR | 6.48% |
| 2012 Q3 | 23.44 Million EUR | -1.99% |
| 2012 FY | 94.79 Million EUR | 10.11% |
| 2012 Q4 | 24.94 Million EUR | 6.38% |
| 2011 Q4 | 19.74 Million EUR | -11.24% |
| 2011 Q3 | 22.24 Million EUR | -0.82% |
| 2011 Q2 | 22.43 Million EUR | 3.56% |
| 2011 FY | 86.08 Million EUR | 2.88% |
| 2011 Q1 | 21.65 Million EUR | 9.78% |
| 2010 FY | 83.67 Million EUR | -0.94% |
| 2010 Q4 | 19.72 Million EUR | -9.28% |
| 2010 Q3 | 21.74 Million EUR | 3.49% |
| 2010 Q2 | 21.01 Million EUR | -0.77% |
| 2010 Q1 | 21.17 Million EUR | 0.0% |
| 2009 FY | 84.46 Million EUR | 2.35% |
| 2008 FY | 82.52 Million EUR | 1.13% |
| 2007 FY | 81.6 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 3.55 Billion EUR | 99.508% |
| Fresenius SE & Co. KGaA | 3.91 Billion EUR | 99.553% |
| LIMES Schlosskliniken AG | 11.2 Million EUR | -56.01% |
| M1 Kliniken AG | 16.77 Million EUR | -4.224% |
| MEDICLIN Aktiengesellschaft | 70.03 Million EUR | 75.038% |
| RHÖN-KLINIKUM Aktiengesellschaft | 162.47 Million EUR | 89.24% |
| VITA 34 AG | 31.36 Million EUR | 44.261% |